Speaker illustration

Doctor Alessandro Di Toro

SAN MATTEO - PAVIA POLYCLINIC HOSPITAL, Pavia (Italy)

Losartan Vs Nebivolol Vs the association of both on the progression of aortic root dilation in genotyped Marfan Syndrome: 48 months open label randomized controlled phase III trial

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Diseases of the aorta: predictors of events and risk modifiers

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb